Financials

News Discussions Technicals Forecast Seasonals

EBITDA of DEXELANCE

Annual data

2022

2023

TTM

‪0.00‬

‪‪13.00 M‬‬

‪‪26.00 M‬‬

‪‪39.00 M‬‬

‪‪52.00 M‬‬

Period

Value

Change

Change %

TTM

‪‪49.18 M‬‬

+‪‪865.00 K‬‬

+‪1.79‬%

2023

‪‪48.32 M‬‬

+‪‪17.86 M‬‬

+‪58.62‬%

2022

‪‪30.46 M‬‬

+‪‪10.83 M‬‬

+‪55.20‬%

Quarterly data

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

‪‪6.00 M‬‬

‪‪12.00 M‬‬

‪‪18.00 M‬‬

‪‪24.00 M‬‬

Period

Value

Change

Change %

Q2 '24

‪‪9.78 M‬‬

+‪‪865.00 K‬‬

+‪9.70‬%

Q1 '24

‪‪8.92 M‬‬

‪‪−11.80 M‬‬

‪−56.95‬%

Q4 '23

‪‪20.72 M‬‬

+‪‪10.96 M‬‬

+‪112.31‬%

Q3 '23

‪‪9.76 M‬‬

‪‪−3.22 M‬‬

‪−24.82‬%

Q2 '23

‪‪12.98 M‬‬

+‪‪4.33 M‬‬

+‪50.01‬%

Q1 '23

‪‪8.65 M‬‬

‪‪−3.79 M‬‬

‪−30.43‬%

Q4 '22

‪‪12.44 M‬‬

+‪‪2.31 M‬‬

+‪22.87‬%

Q3 '22

‪‪10.12 M‬‬

+‪‪4.79 M‬‬

+‪89.71‬%

Q2 '22